Status:
UNKNOWN
Efficacy of Median Nerve Hydrodissection by Hyalase Versus Midazolam in the Treatment of Carpal Tunnel Syndrome:
Lead Sponsor:
Minia University
Conditions:
Pain, Neuropathic
Eligibility:
All Genders
30-70 years
Phase:
EARLY_PHASE1
Brief Summary
Comparing efficacy of hyalase and midazolam in median nerve entrapement neuropathy
Eligibility Criteria
Inclusion
- adult patients (30 - 70 years old) complaining of carpal tunnel syndrome of 3 month duration or more , diagnosed axonal neuropathy using electrodiagnosis , nerve conduction study refractory to medical treatment for 2 months .
Exclusion
- Diabetic patients
- Pregnant population .
- Refusal to participate
Key Trial Info
Start Date :
January 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05344495
Start Date
January 10 2022
End Date
August 1 2022
Last Update
June 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mina Raouf
ALMinya, Minya Governorate, Egypt, 6115